---
title: "Other early adjunctive therapy of acute coronary syndromes"
slug: "other-early-adjunctive-therapy-of-acute-coronary-syndromes"
date: "2023-07-23"
enableToc: false
tags:
  - building
---

> [!info]
>
> ðŸŒ± ä¾†è‡ª: [[acute coronary syndromes]]

# Other early adjunctive therapy of acute coronary syndromes

- High-intensity statin therapy (eg, at â†£ orva 80 mg qd; PROVE-IT TIMI 22, NEJM 2004;350:1495);
  - â†“ ischemic events w/ benefit emerging w/in wks (JAMA 2001;285:1711 & JACC 2005;46:1405);
  - â†“ peri-PCI MI (JACC 2010;56:1099);
  - ? â†“ contrast-induced nephropathy (NEJM 2019;380:2156)
- Ezetimibe:
  - â†“ CV events when added to statin (IMPROVE-IT, NEJM 2015;372:2387)
- ACEI/ARB:
  - start once hemodynamics and renal function stable (hold if anticipate CABG)
  - Strong indication for ACEI/ARB if
  - heart failure,
  - EF <40%,
  - HTN,
  - DM,
  - CKD; ~10% â†“ mortality,
  - greatest benefit in ant. STEMI or prior MI (Lancet 1994;343:1115 & 1995;345:669)
  - [[IABP as early adjunctive therapy of acute coronary syndromes]] ó°’–: can be used for refractory angina when PCI not available
